Apr. 02 2024
Source Page: Kidney CancerFound: Kidney Cancer
Aug. 14 2024
Source Page: Relugolix for treating hormone-sensitive prostate cancerFound: Relugolix for treating hormone-sensitive prostate cancer
Jul. 18 2024
Source Page: 2023 National Cancer Patient Experience Survey resultsFound: 2023 National Cancer Patient Experience Survey results
Aug. 14 2024
Source Page: Relugolix for treating hormone-sensitive prostate cancerFound: Relugolix for treating hormone-sensitive prostate cancer
Jun. 13 2011
Source Page: Table showing NHS budgeting for Cancer and Lung Cancer for England, cancer network and PCTs, for the years 2004/05 to 2009/10. 20 p.Found: Table showing NHS budgeting for Cancer and Lung Cancer for England, cancer network and PCTs, for the
Jul. 19 2024
Source Page: Relugolix for treating hormone-sensitive prostate cancer [ID6187]Found: Relugolix for treating hormone-sensitive prostate cancer [ID6187]
Sep. 10 2024
Source Page: Scottish Cancer Patient Experience Survey 2024 Technical ReportFound: Scottish Cancer Patient Experience Survey 2024 Technical Report
Jul. 19 2024
Source Page: Relugolix for treating hormone-sensitive prostate cancerFound: Relugolix for treating hormone-sensitive prostate cancer
Aug. 14 2024
Source Page: Relugolix for treating hormone-sensitive prostate cancerFound: Relugolix for treating hormone-sensitive prostate cancer
Nov. 01 2010
Source Page: The cancer drugs fund: a consultation paper. 22 p.Found: The cancer drugs fund: a consultation paper. 22 p.